Synapse - Works

Results (4640)

Systemic therapy for gallbladder cancer

Review

Javle, M.; Zhao, H.; Abou-Alfa, G. K.
Chinese Clinical Oncology (2019)

A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

Journal Article

Hu, Z. I.; Bendell, J. C.; Bullock, A.; LoConte, N. K.; Hatoum, H.; Ritch, P.; Hool, H.; Leach, J. W.; Sanchez, J.; Sohal, D. P. S.; more...
Cancer Medicine (2019)

Fulltext@MSK | Save

Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma

Journal Article

Boas, F. E.; Brown, K. T.; Ziv, E.; Yarmohammadi, H.; Sofocleous, C. T.; Erinjeri, J. P.; Harding, J. J.; Solomon, S. B.
American Journal of Roentgenology (2019)

Fulltext@MSK | Save

ANCHOR CRC: A phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BIM), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC)

Meeting Abstract

Grothey, A.; Yaeger, R.; Paez, D.; Tabernero, J.; Taïeb, J.; Yoshino, T.; Groc, M.; Vedovato, J.; Chetaille, E.; Van Cutsem, E.
Annals of Oncology (2019)

Fulltext@MSK | Save

Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC)

Meeting Abstract

Miksad, R.; Cicin, I.; Chen, Y.; Klumpen, H.; Kim, S.; Lin, Z.; Youkstetter, J.; Sen, S.; Cheng, A.; Meyer, T.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase 3 multicenter, open-label, randomized study of infigratinib versus gemcitabine plus cisplatin in the first-line treatment of patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: The PROOF trial

Meeting Abstract

Javle, M.; Borbath, I.; Clarke, S.; Hitre, E.; Louvet, C.; Macarulla, T.; Oh, D.; Spratlin, J.; Valle, J.; Weiss, K.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: A double-blind, randomized, placebo-controlled phase 3 study

Meeting Abstract

Chung, H.; Bang, Y.; Fuchs, C.; Qin, S.; Satoh, T.; Shitara, K.; Tabernero, J.; Van Cutsem, E.; Cao, Z.; Chen, X.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Comparative analyses between younger and older patients with pancreatic adenocarcinoma: Differences in clinicopathological features, treatment patterns, and outcomes

Meeting Abstract

Salem, M.; Kadakia, K.; Trufan, S.; Hwang, J.; Nazemzadeh, R.; Jagosky, M.; Worrilow, W.; Coley, H.; Al Hallak, M.; Gower, N.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): Primary analysis and quality of life outcomes

Meeting Abstract

Reni, M.; Riess, H.; O'Reilly, E.; Santoro, A.; Park, J.; Bekaii-Saab, T.; Tempero, M.; Shan, Y.; Macarulla, T.; Van Cutsem, E.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Analysis of patient screening in the phase III, international, randomized, open-label APACT trial

Meeting Abstract

Reni, M.; Winter, J.; Tortora, G.; Pelzer, U.; Riess, H.; Chang, H.; O'Reilly, E.; Oh, D.; Diaz, I. A.; Milella, M.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save